1. Home
  2. SAIC vs RNA Comparison

SAIC vs RNA Comparison

Compare SAIC & RNA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo SCIENCE APPLICATIONS INTERNATIONAL CORPORATION

SAIC

SCIENCE APPLICATIONS INTERNATIONAL CORPORATION

HOLD

Current Price

$114.73

Market Cap

4.8B

Sector

Technology

ML Signal

HOLD

Logo Avidity Biosciences Inc.

RNA

Avidity Biosciences Inc.

HOLD

Current Price

$72.34

Market Cap

4.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SAIC
RNA
Founded
1969
2012
Country
United States
United States
Employees
N/A
N/A
Industry
EDP Services
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
4.8B
4.0B
IPO Year
N/A
2020

Fundamental Metrics

Financial Performance
Metric
SAIC
RNA
Price
$114.73
$72.34
Analyst Decision
Buy
Buy
Analyst Count
9
20
Target Price
$119.44
$69.26
AVG Volume (30 Days)
555.9K
2.1M
Earning Date
12-04-2025
02-26-2026
Dividend Yield
1.30%
N/A
EPS Growth
33.14
N/A
EPS
7.83
N/A
Revenue
$7,350,000,000.00
$20,868,000.00
Revenue This Year
N/A
$57.30
Revenue Next Year
$1.75
$28.41
P/E Ratio
$14.56
N/A
Revenue Growth
N/A
106.27
52 Week Low
$84.16
$21.51
52 Week High
$124.11
$72.61

Technical Indicators

Market Signals
Indicator
SAIC
RNA
Relative Strength Index (RSI) 75.22 72.34
Support Level $100.00 $72.04
Resistance Level $103.58 $72.47
Average True Range (ATR) 2.85 0.18
MACD 0.97 -0.20
Stochastic Oscillator 95.03 73.68

Price Performance

Historical Comparison
SAIC
RNA

About SAIC SCIENCE APPLICATIONS INTERNATIONAL CORPORATION

Science Applications International Corp provides technical, engineering, and enterprise IT services mainly to the U.S. government. Specifically, it offers end-to-end solutions spanning the design, development, integration, deployment, management and operations, sustainment, and security of the customer's entire IT infrastructure. The company has two reportable segments which include Defense and Intelligence and the Civilian segment. Maximum revenue is generated from its Defense and Intelligence segment, which provides a diverse portfolio of national security solutions to the Department of Defence (DoD) and the Intelligence Community of the United States Government. The Civilian segment provides solutions to the civilian markets, encompassing federal, state, and local governments.

About RNA Avidity Biosciences Inc.

Avidity Biosciences Inc is a biopharmaceutical company committed to delivering a new class of RNA therapeutics called Antibody Oligonucleotide Conjugates, or AOCs. Company's pipeline currently has three programs in potentially registrational clinical trials: DM1, FSHD, and DMD. The segments includes following: Del-zota for DMD44, Del-desiran for DM1, Del-brax for FSHD.

Share on Social Networks: